僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Parsatuzumab （Anti-EGFL7; RG 7414） is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor （VEGF） inhibition